Welsis (WLSS) Cash & Current Investments (2022 - 2023)

Welsis (WLSS) posted quarterly Cash & Current Investments of $1368.0 for Q4 2023, down 90.43% year-over-year from $14292.0 in Q4 2022, and down 86.09% quarter-over-quarter from $9834.0 in Q3 2023.

Welsis (WLSS) Cash & Current Investments (2022 - 2023) Analysis & Trends

Welsis' Cash & Current Investments history runs 2 years deep, the most recent figure standing at $1368.0 for Q4 2023.

  • In Q4 2023, Cash & Current Investments fell 90.43% year-over-year to $1368.0; the TTM figure through Dec 2023 stood at $1368.0 (down 90.43% YoY), while the FY2023 annual figure was $9834.0, down 47.42% from the prior year.
  • Cash & Current Investments for Q4 2023 stood at $1368.0, down from $9834.0 in the prior quarter.
  • The five-year high for Cash & Current Investments was $18703.0 in Q3 2022, with the low at $963.0 in Q1 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Veeva Systems 39.72 Bn 32.40 Bn 662.02 Mn 7.31 Bn
2 BrightSpring Health Services 12.19 Bn 11.64 Bn 492.75 Mn 561.98 Mn
3 Healthequity 8.79 Bn 8.52 Bn 256.31 Mn 265.37 Mn
4 10x Genomics 7.31 Bn 6.76 Bn 112.50 Mn 552.03 Mn
5 Hinge Health 7.10 Bn 6.71 Bn 183.95 Mn 389.39 Mn
6 MiniMed 5.66 Bn 5.36 Bn 480.00 Mn 298.00 Mn
7 Waystar Holding 4.76 Bn 4.56 Bn 221.99 Mn 191.60 Mn
8 Doximity 4.46 Bn 3.77 Bn 132.93 Mn 687.79 Mn
9 Heartflow 3.66 Bn 3.28 Bn 53.19 Mn 374.99 Mn
10 Welsis 1.65 Mn 1.65 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2023 1,368.00
Sep 30, 2023 9,834.00
Jun 30, 2023 5,202.00
Mar 31, 2023 963.00
Dec 31, 2022 14,292.00
Sep 30, 2022 18,703.00
Jun 30, 2022 1,640.00